An observational study in Lymph Nodes, sponsored by Gachon University Gil Medical Center. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2024-08-19.
Sponsored by Gachon University Gil Medical Center · Observational
Recently, intralymphatic allergen-specific immunotherapy (ILIT) showed promising treatment outcomes for allergic rhinoconjunctivitis. However, the normal size distribution of superficial lymph nodes (LNs) on the trunk that are potential target LNs for ILIT has not been evaluated.
The objective of this study is to investigate the distribution of LN size in inguinal and axillary area.
In this study, the long-axis diameters of the largest LNs in the inguinal and axillary areas were retrospectively measured in subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes from September 2022 to November 2022.
Gachon University Gil Medical Center is the lead sponsor of 90 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes
Diagnostic Test: chest and abdominoplevic CT
chest and abdominopelvic computed tomography on the same day for health screening purposes
Inguinal LN size
The long-axis diameter of the largest inguinal lymph node
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Axillary LN size
The long-axis diameter of the largest axillary lymph node
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Subjects with inguinal LN size ≥ 10mm
The number of subjects in whom the long-axis diameter of the largest inguinal lymph node is 10 mm or more.
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Subjects with axillary LN size ≥ 10mm
The number of subjects in whom the long-axis diameter of the largest axillary lymph node is 10 mm or more.
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between inguinal and axillary LN sizes
Correlation between the long-axis diameter of the largest LNs in inguinal area and those in axillary area
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between inguinal LN size and age
Correlation between the long-axis diameter of the largest inguinal LN and age
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between axillary LN size and age
Correlation between the long-axis diameter of the largest axillary LN and age
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between inguinal LN size and height
Correlation between the long-axis diameter of the largest inguinal LN and height
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between axillary LN size and height
Correlation between the long-axis diameter of the largest axillary LN and height
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between inguinal LN size and BMI
Correlation between the long-axis diameter of the largest inguinal LN and BMI
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between axillary LN size and BMI
Correlation between the long-axis diameter of the largest axillary LN and BMI
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between inguinal LN size and weight
Correlation between the long-axis diameter of the largest inguinal LN and weight
Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022
Correlation between axillary LN size and weight
Correlation between the long-axis diameter of the largest axillary LN and weight
Time frame: On the day when chest and abdominopelvic CT was during the study period from 1st SEP 2022 to 30th NOV 2022
Plan to share: No — I think that IPD of this observational retrospective mono-center pilot study needs not be shared.
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gachon University Gil Medical Center